{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:13:17Z","timestamp":1788811997705,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":95,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thyroid Res"],"DOI":"10.1186\/s13044-026-00303-9","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:53:14Z","timestamp":1780588394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Time to euthyroidism and its predictors among thyrotoxicosis patients on antithyroid drugs at tertiary hospitals, Western Oromia, Ethiopia: a retrospective cohort study"],"prefix":"10.1186","volume":"19","author":[{"given":"Bokasa","family":"Negeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiru","family":"Merdassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meseret Belete","family":"Fite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesfaye","family":"Shibiru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firomsa","family":"Bekele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"303_CR1","unstructured":"Nadiya F. Clinical Treatment Guideline for the Management of. 2024."},{"issue":"10","key":"303_CR2","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343\u2013421.","journal-title":"Thyroid"},{"issue":"2","key":"303_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.emc.2013.12.001","volume":"32","author":"D Devereaux","year":"2014","unstructured":"Devereaux D, Tewelde SZ. Hyperthyroidism and thyrotoxicosis. Emerg Med Clin North Am. 2014;32(2):277\u201392.","journal-title":"Emerg Med Clin North Am"},{"issue":"May","key":"303_CR4","first-page":"1","volume":"14","author":"J Wu","year":"2023","unstructured":"Wu J, Lin X, Huang X, Shen Y, Shan PF. Global, regional and national burden of endocrine, metabolic, blood and immune disorders 1990\u20132019: a systematic analysis of the Global Burden of Disease study 2019. Front Endocrinol (Lausanne). 2023;14(May):1\u201313.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"303_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrendo.2018.18","volume":"14","author":"PN Taylor","year":"2018","unstructured":"Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018;14(5):301\u201316.","journal-title":"Nat Rev Endocrinol"},{"key":"303_CR6","doi-asserted-by":"crossref","unstructured":"Censi S, Salmaso L, Ceccato F, Manso J, Fedeli U, Saia M, et al. Hyperthyroidism incidence in a large population-based study in northeastern Italy. Endocr Connect. 2023;12(12).","DOI":"10.1530\/EC-23-0292"},{"key":"303_CR7","doi-asserted-by":"publisher","unstructured":"Azeez TA, Adetunji TA, Adio M. Thyrotoxicosis in Africa: a systematic review and meta-analysis of the clinical presentation. Egypt J Intern Med [Internet]. 2022;34(1). Available from: https:\/\/doi.org\/10.1186\/s43162-022-00145-5.","DOI":"10.1186\/s43162-022-00145-5"},{"issue":"6","key":"303_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4103\/2230-8210.83331","volume":"15","author":"A Ogbera","year":"2011","unstructured":"Ogbera A, Kuku S. Epidemiology of thyroid diseases in Africa. Indian J Endocrinol Metab. 2011;15(6):82.","journal-title":"Indian J Endocrinol Metab"},{"key":"303_CR9","unstructured":"Masikane S, Mkhize T, Harry L, Gabela L, Nxasana T, Ndlovu N et al. Efficacy of a fixed low dose of radioactive iodine in the treatment of Graves\u2019 disease in Sub-Saharan Africa. Hell J Nucl Med [Internet]. 2024 Sep 1 [cited 2026 Mar 21];27(3):176\u201380. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39644268\/."},{"issue":"9","key":"303_CR10","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.21037\/gs-21-236","volume":"10","author":"M Hussein","year":"2021","unstructured":"Hussein M, Toraih E, Reisner ASC, Miller P, Corsetti R, Kandil E. Prevalence and mortality of cardiovascular events in patients with hyperthyroidism: a nationwide cohort study in the United States. Gland Surg. 2021;10(9):2608\u201321.","journal-title":"Gland Surg"},{"issue":"1","key":"303_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.31762\/AHJ2433.0101","volume":"33","author":"BJ David","year":"2024","unstructured":"David BJ, Buot BCJ, Castro R. STEMI and Thyroid Storm: A Case Report of Thyrotoxicosis-Induced Cardiomyopathy. ASEAN Hear J. 2024;33(1):1\u20133.","journal-title":"ASEAN Hear J"},{"issue":"3","key":"303_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/2042018810382481","volume":"1","author":"R Carroll","year":"2010","unstructured":"Carroll R, Matfin G, Review. Endocrine and metabolic emergencies: Thyroid storm. Ther Adv Endocrinol Metab. 2010;1(3):139\u201345.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"5","key":"303_CR13","doi-asserted-by":"publisher","first-page":"944","DOI":"10.5114\/aoms.2013.38685","volume":"9","author":"S Ertek","year":"2013","unstructured":"Ertek S, Cicero AF. Hyperthyroidism and cardiovascular complications: A narrative review on the basis of pathophysiology. Arch Med Sci. 2013;9(5):944\u201352.","journal-title":"Arch Med Sci"},{"issue":"3","key":"303_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s40256-024-00717-6","volume":"25","author":"SY Sohn","year":"2025","unstructured":"Sohn SY, Kim YJ, Cho S, Cho SW. Incidence and Risk Factors for Amiodarone-Induced Thyroid Dysfunction: A Nationwide Retrospective Cohort Study. Am J Cardiovasc Drugs. 2025;25(3):419\u201325.","journal-title":"Am J Cardiovasc Drugs"},{"key":"303_CR15","doi-asserted-by":"crossref","unstructured":"Shekhda KM, Zlatkin V, Khoo B, Armeni E. Thyrotoxicosis due to gestational trophoblastic disease: unmet needs in the management of gestational thyrotoxicosis. Case Rep Endocrinol. 2024;2024.","DOI":"10.1155\/2024\/5318871"},{"key":"303_CR16","unstructured":"Stone MB, Wallace RB. Medicare coverage of routine screening for thyroid dysfunction. Medicare Coverage of Routine Screening for Thyroid Dysfunction; 2003."},{"issue":"6","key":"303_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.18410\/jebmh\/2017\/51","volume":"4","author":"PMM Kannan","year":"2017","unstructured":"Kannan PMM. the Value of Bedside Ultrasound in the Diagnosis of Thyrotoxicosis and Thyrotoxic Cardiac Emergencies- a Short-Term Study. J Evid Based Med Healthc. 2017;4(6):269\u201373.","journal-title":"J Evid Based Med Healthc"},{"issue":"1","key":"303_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.18203\/2349-3933.ijam20233887","volume":"11","author":"IKO Widiana","year":"2023","unstructured":"Widiana IKO, Wulandari DC. Thyroid storm in an uncontrolled graves\u2019 disease with multiple complications: a case report. Int J Adv Med. 2023;11(1):37\u201342.","journal-title":"Int J Adv Med"},{"key":"303_CR19","doi-asserted-by":"publisher","unstructured":"Jonklaas J. Is euthyroidism within reach for all? Expert Rev Endocrinol Metab [Internet]. 2023;18(6):455\u20138. Available from: https:\/\/doi.org\/10.1080\/17446651.2023.2267120.","DOI":"10.1080\/17446651.2023.2267120"},{"issue":"July","key":"303_CR20","first-page":"1","volume":"13","author":"J Jonklaas","year":"2022","unstructured":"Jonklaas J. Restoration of euthyroidism with levothyroxine: implications of etiology of hypothyroidism and the degree of residual endogenous thyroid function. Front Endocrinol (Lausanne). 2022;13(July):1\u201310.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"303_CR21","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1210\/jc.2014-3586","volume":"100","author":"AR Cappola","year":"2015","unstructured":"Cappola AR, Arnold AM, Wulczyn K, Carlson M, Robbins J, Psaty BM. Thyroid function in the euthyroid range and adverse outcomes in older adults. J Clin Endocrinol Metab. 2015;100(3):1088\u201396.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"303_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000490384","volume":"7","author":"GJ Kahaly","year":"2018","unstructured":"Kahaly GJ, Bartalena L, Heged\u00fcs L, Leenhardt L, Poppe K, Pearce SH. 2018 European thyroid association guideline for the management of graves\u2019 hyperthyroidism. Eur Thyroid J. 2018;7(4):167\u201386.","journal-title":"Eur Thyroid J"},{"issue":"4","key":"303_CR23","doi-asserted-by":"publisher","first-page":"e238655","DOI":"10.1001\/jamanetworkopen.2023.8655","volume":"6","author":"SY Lee","year":"2023","unstructured":"Lee SY, Modzelewski KL, Law AC, Walkey AJ, Pearce EN, Bosch NA. Comparison of Propylthiouracil vs Methimazole for Thyroid Storm in Critically Ill Patients. JAMA Netw Open. 2023;6(4):e238655.","journal-title":"JAMA Netw Open"},{"key":"303_CR24","doi-asserted-by":"crossref","unstructured":"Orgiazzi J. Antithyroid drugs. Encycl Endocr Dis. 2018;683\u20137.","DOI":"10.1016\/B978-0-12-801238-3.04148-9"},{"key":"303_CR25","unstructured":"FMOH. Standard treatment guidelines for general hospitals fourth edition. 2021. Fmoh. 2021;4:1\u20131201."},{"issue":"1","key":"303_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13044-019-0064-2","volume":"12","author":"EA Gebreyohannes","year":"2019","unstructured":"Gebreyohannes EA, Ayele EM, Tesfaye SA, Seid MA. Normalization of thyroid function tests among thyrotoxicosis patients attending a University Hospital in North-West Ethiopia. Thyroid Res. 2019;12(1):1\u20138.","journal-title":"Thyroid Res"},{"issue":"1","key":"303_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5812\/ijem-140956","volume":"22","author":"N Saadat","year":"2024","unstructured":"Saadat N, Masoumi S, Shahrzad MK, Azizi F. Sustained Euthyroidism during Thionamide Antithyroid Drug Treatment: Comparison of Short-and Long-term Methimazole Therapy. Int J Endocrinol Metab. 2024;22(1):1\u20137.","journal-title":"Int J Endocrinol Metab"},{"key":"303_CR28","doi-asserted-by":"crossref","unstructured":"Malboosbaf R, Azizi F. Long-term treatment with antithyroid drugs: efficacy and safety. Int J Endocrinol Metab. 2020;18(6).","DOI":"10.5812\/ijem.101487"},{"key":"303_CR29","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.2147\/TCRM.S312810","volume":"17","author":"H Maldey","year":"2021","unstructured":"Maldey H, Tadesse S, Alem AZ, Hagezom HM, Gufue ZH. Time to euthyroidism and its determinants among thyrotoxicosis patients on anti-thyroid drug who attend to medical and ambulatory clinics of south tigrai general hospitals. Ther Clin Risk Manag. 2021;17:1091\u2013101.","journal-title":"Ther Clin Risk Manag"},{"key":"303_CR30","doi-asserted-by":"publisher","unstructured":"Shaka H, Salim M, DeHart L, El-amir Z, Wani F, Kichloo A. A decade of hospitalizations for hyperthyroidism in the US. Baylor Univ Med Cent Proc [Internet]. 2022;35(6):773\u20137. Available from: https:\/\/doi.org\/10.1080\/08998280.2022.2106452.","DOI":"10.1080\/08998280.2022.2106452"},{"key":"303_CR31","doi-asserted-by":"publisher","unstructured":"Jonklaas J. Is euthyroidism within reach for all? Expert Rev Endocrinol Metab. 2023;18:455\u2013458. https:\/\/doi.org\/10.1080\/17446651.2023.2267120.","DOI":"10.1080\/17446651.2023.2267120"},{"key":"303_CR32","doi-asserted-by":"publisher","unstructured":"Vasilopoulou A, Patsiou V, Bekiaridou A, Papazoglou AS, Moysidis DV, Spaho M, et al. Prognostic implications of thyroid disease in patients with atrial fibrillation. Heart Vessels. 2024;39(2):185\u201393. Available from: https:\/\/doi.org\/10.1007\/s00380-023-02341-x.","DOI":"10.1007\/s00380-023-02341-x"},{"issue":"1","key":"303_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13044-019-0064-2","volume":"12","author":"EA Gebreyohannes","year":"2019","unstructured":"Gebreyohannes EA, Ayele EM, Tesfaye SA, Seid MA. Normalization of thyroid function tests among thyrotoxicosis patients attending a University Hospital in North-West Ethiopia. Thyroid Res. 2019;12(1):3.","journal-title":"Thyroid Res"},{"issue":"07","key":"303_CR34","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.47191\/ijcsrr\/V8-i7-50","volume":"08","author":"DK Minasie","year":"2025","unstructured":"Minasie DK, Shukri MK, Bosha YA, Bosha KA, Shumye AH, Zewde WZ, et al. Time to Normalization of Thyroid Function Tests and Associated Factors Among Thyrotoxic Patients at Saint Paul\u2019s Hospital Millennium Medical College Endocrine Clinic, Addis Ababa, Ethiopia, 2024. Int J Curr Sci Res Rev. 2025;08(07):3633\u201347.","journal-title":"Int J Curr Sci Res Rev"},{"issue":"5","key":"303_CR35","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3803\/EnM.2022.1553","volume":"37","author":"CK Jung","year":"2022","unstructured":"Jung CK, Bychkov A, Kakudo K. Update from the 2022 World Health Organization classification of thyroid tumors: a standardized diagnostic approach. Endocrinol Metab. 2022;37(5):703\u201318.","journal-title":"Endocrinol Metab"},{"key":"303_CR36","doi-asserted-by":"crossref","unstructured":"Vija Racaru L, Grunenwald S, Hindie E, Taieb D, Clerc J, Zerdoud S. Management of adenomas and toxic multinodular goiters with Iodine 131. Med Nucl [Internet]. 2020;44(4):272\u20136. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0928125820302126.","DOI":"10.1016\/j.mednuc.2020.09.001"},{"issue":"6","key":"303_CR37","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3803\/EnM.2022.1476","volume":"37","author":"F Azizi","year":"2022","unstructured":"Azizi F, Saadat N, Takyar MA, Abdi H, Mehran L, Amouzegar A. Efficacy and Safety of Long-Term Methimazole versus Radioactive Iodine in the Treatment of Toxic Multinodular Goiter. Endocrinol Metab. 2022;37(6):861\u20139.","journal-title":"Endocrinol Metab"},{"key":"303_CR38","unstructured":"Douglas S, Ross M, David S, Cooper M, Jean E, Mulder M. Treatment of toxic adenoma and toxic multinodular goiter. UpToDate, Literature Review Current Through."},{"issue":"3","key":"303_CR39","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1530\/EJE-13-0811","volume":"170","author":"E Mohlin","year":"2014","unstructured":"Mohlin E, Nystr\u00f6m HF, Eliasson M. Long-term prognosis after medical treatment of Graves\u2019 disease in a northern Swedish population 2000\u20132010. Eur J Endocrinol. 2014;170(3):419\u201327.","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"303_CR40","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1001\/archinte.160.8.1067","volume":"160","author":"KA Woeber","year":"2000","unstructured":"Woeber KA. Update on the management of hyperthyroidism and hypothyroidism. Arch Intern Med. 2000;160(8):1067\u201371.","journal-title":"Arch Intern Med"},{"key":"303_CR41","doi-asserted-by":"crossref","unstructured":"Hafed AB, Abdulkareem RK, Almalki AM, Alradadi JI, Aldosari A, Khan ZH. Assessment of thyroid function in chronic kidney disease patients at King Abdulaziz Medical City. Cureus. 2024;16(11).","DOI":"10.7759\/cureus.73180"},{"issue":"5","key":"303_CR42","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/MED.0000000000000275","volume":"23","author":"CM Rhee","year":"2016","unstructured":"Rhee CM. The interaction between thyroid and kidney disease: An overview of the evidence. Curr Opin Endocrinol Diabetes Obes. 2016;23(5):407\u201315.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"10","key":"303_CR43","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.18203\/2320-6012.ijrms20194192","volume":"7","author":"HV Khandait","year":"2019","unstructured":"Khandait HV, Ambulkar SG, Tayde PS. Clinical profile of thyrotoxicosis and related cardiovascular morbidities among patients attending endocrine outpatient department in a tertiary care centre. Int J Res Med Sci. 2019;7(10):3666.","journal-title":"Int J Res Med Sci"},{"issue":"6","key":"303_CR44","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1089\/105072502760143908","volume":"12","author":"DD Ascheim","year":"2002","unstructured":"Ascheim DD, Hryniewicz K. Thyroid hormone metabolism in patients with congestive heart failure: The low triiodothyronine state. Thyroid. 2002;12(6):511\u20135.","journal-title":"Thyroid"},{"issue":"3","key":"303_CR45","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000469708","volume":"6","author":"R Janssen","year":"2017","unstructured":"Janssen R, Muller A, Simonides WS. Cardiac Thyroid Hormone Metabolism and Heart Failure. Eur Thyroid J. 2017;6(3):130\u20137.","journal-title":"Eur Thyroid J"},{"key":"303_CR46","doi-asserted-by":"publisher","unstructured":"Chehade JM, Belal HF. Cross-section of thyroidology and nephrology: Literature review and key points for clinicians. J Clin Transl Endocrinol [Internet]. 2024;37(March):100359. Available from: https:\/\/doi.org\/10.1016\/j.jcte.2024.100359.","DOI":"10.1016\/j.jcte.2024.100359"},{"key":"303_CR47","doi-asserted-by":"crossref","unstructured":"Mohamedali M, Reddy Maddika S, Vyas A, Iyer V, Cheriyath P. Thyroid disorders and chronic kidney disease. Int J Nephrol. 2014;2014:1\u20136.","DOI":"10.1155\/2014\/520281"},{"issue":"2","key":"303_CR48","first-page":"2","volume":"15","author":"R Naguib","year":"2023","unstructured":"Naguib R, Elkemary E. Thyroid Dysfunction and Renal Function: A Crucial Relationship to Recognize. Cureus. 2023;15(2):2\u20136.","journal-title":"Cureus"}],"container-title":["Thyroid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13044-026-00303-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-026-00303-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-026-00303-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:02:30Z","timestamp":1788811350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13044-026-00303-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["303"],"URL":"https:\/\/doi.org\/10.1186\/s13044-026-00303-9","relation":{},"ISSN":["1756-6614"],"issn-type":[{"value":"1756-6614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study approved by Institutional Ethical review committee of the Institute of Health Sciences, Wollega University (Ref. No: IHSREC\/04\/140\/ 2024), before data collection and the supporting letter obtained from both hospitals medical directors. The requirement of Informed consent was waived by Ethical review committee of the Institute of Health Sciences, Wollega University. Privacy and confidentiality was ensured during collection of patients\u2019 information by coding data instead of using personal identifiers. Thus, name and address of patients were not recorded in the data abstraction format. The study protocol was performed in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable, No individual person\u2019s personal details, images, or videos are being used in this study.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24"}}